Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed PTCL

NCT00840385 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT00840385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00840385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed PTCL
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2007
Completion date
November 30, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, t-cell lymphomas